logo

For the Inventor, By the Inventor

Kaohsiung, Taiwan

Ping-Heng Tan

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: I-Shou University. Active years: 2013-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ping-Heng Tan. Retrieved from https://idiyas.com/inventor/ping-heng-tan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal4 out of 107 
 
I-Shou University
 patents

Years Active: 2013-2015

Loading Chart...
4 patents (USPTO):Explore Patents
1. 9216190 - Analgesic method (2015-12-22),
2. 8575330 - MicroRNA-based short hairpin RNA for gene knockdown of NR1 subunit of N-methyl-D-aspartate receptor and its application on pharmaceutics (2013-11-05),
3. 8372817 - Small interfering RNA for gene knockdown of the subcutaneous N-methyl-D-aspartate receptor NR1 subunit, and it's application on pharmaceutics (2013-02-12),
4. 8361985 - Short hairpin RNA for gene knockdown of NR1 subunit of the N-methyl-D-aspartate receptor and its application on pharmaceutics (2013-01-29),

Title: Innovations of Ping-Heng Tan in Analgesic Methods and Gene Silencing

Introduction

Ping-Heng Tan is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the fields of pharmacology and genetic engineering. With a total of four patents to his name, his work focuses on innovative methods for pain relief and gene knockdown techniques.

Latest Patents

One of his latest patents is an analgesic method that includes an oligonucleotide, specifically a double strand RNA comprising 18 to 70 base pairs. This analgesic medication is designed to deliver the oligonucleotide into cells using a pharmaceutical acceptable vehicle. The dosage of the oligonucleotide in the analgesic ranges from 50 to 200 µg/kg per time, with the vehicle selected from polyethyleneimine, lipofectamine, and iFect. Another significant patent involves a microRNA-based short hairpin RNA for gene knockdown of the NR1 subunit of the N-methyl-D-aspartate receptor. This invention relates to gene silencing through a single strand RNA fragment that includes complementary fragments and a connecting fragment, which is crucial for the genetic expression of the NR1 subunit.

Career Highlights

Ping-Heng Tan is affiliated with I-Shou University, where he continues to engage in research and development in his areas of expertise. His work has implications for both therapeutic applications and advancements in genetic research.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Ping-Heng Tan's innovative patents in analgesic methods and gene silencing demonstrate his significant contributions to science and medicine. His work continues to pave the way for advancements in pharmacological treatments and genetic engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…